Suppr超能文献

阶段特异性CAR介导的信号传导从诱导多能干细胞产生幼稚样、无TCR的CAR T细胞。

Stage-specific CAR-mediated signaling generates naïve-like, TCR-null CAR T cells from induced pluripotent stem cells.

作者信息

Yoo Sang Pil, Yuan Xuegang, Engstrom Claire, Chang Patrick, Li Suwen, Lathrop Lindsay, Lagosh Jessica, Seet Christopher, Kohn Donald B, Crooks Gay M

出版信息

bioRxiv. 2024 Nov 28:2024.11.25.624041. doi: 10.1101/2024.11.25.624041.

Abstract

Genetically modified, induced pluripotent stem cells (iPSCs) offer a promising allogeneic source for the generation of functionally enhanced, chimeric antigen receptor (CAR) T cells. However, the signaling of CARs during early T cell development and the removal of the endogenous T cell receptor required to prevent alloreactivity pose significant challenges to the production of mature conventional CAR T cells from iPSCs. Here, we show that TCR-null, CD8αβ CAR T cells can be efficiently generated from iPSCs by engineering stage-specific onset of CAR expression and signaling to both permit conventional T cell development and to induce efficient positive selection. CAR T cells produced using this approach displayed a uniform, naïve T cell phenotype and demonstrated superior antigen-specific cytotoxicity compared to iPSC-derived effector memory CAR T cells. Multimodal sequencing revealed CAR-mediated positive selection induced the persistent upregulation of key transcription factors involved in naïve T cell development. Achieving precise control of CAR expression and signaling in developmentally sensitive T precursors will be critical to realizing the full potential for "off-the-shelf", iPSC-derived cellular therapies.

摘要

基因改造的诱导多能干细胞(iPSC)为生成功能增强的嵌合抗原受体(CAR)T细胞提供了一种很有前景的异基因来源。然而,CAR在早期T细胞发育过程中的信号传导以及去除防止同种异体反应所需的内源性T细胞受体,对从iPSC生产成熟的传统CAR T细胞构成了重大挑战。在此,我们表明,通过设计CAR表达和信号传导的阶段特异性起始,可从iPSC高效生成TCR缺失的CD8αβ CAR T细胞,以允许传统T细胞发育并诱导有效的阳性选择。使用这种方法产生的CAR T细胞表现出均匀的初始T细胞表型,并且与iPSC衍生的效应记忆CAR T细胞相比,表现出更强的抗原特异性细胞毒性。多模态测序显示,CAR介导的阳性选择诱导了参与初始T细胞发育的关键转录因子的持续上调。在发育敏感的T前体细胞中实现对CAR表达和信号传导的精确控制,对于实现“现货供应”的iPSC衍生细胞疗法的全部潜力至关重要。

相似文献

引用本文的文献

1
Cell therapies for immune-mediated disorders.用于免疫介导性疾病的细胞疗法。
Front Med (Lausanne). 2025 Mar 26;12:1550527. doi: 10.3389/fmed.2025.1550527. eCollection 2025.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验